Ingredients in some vitamin supplements may cause hives or a skin rash. Treatments include antihistamines and topical corticosteroids.

A growing number of people have reported developing unexpected skin rashes during or after a COVID-19 infection, leading ...

From relentless itching and painful flare-ups to sleepless nights and emotional exhaustion, eczema can take a serious toll on ...

Every two weeks remains approved as a dosing regimen of Elfabrio in the EU --PARMA, Italy and CARMIEL, Israel, Nov. 03, 2025 ...

A case of membranoproliferative glomerulonephritis with immune depositions in the kidney was reported during clinical trials. Monitor serum creatinine and urinary protein-to-creatinine ratio. If ...

Generated $459 million in 3Q 2025 revenues, including $178 million in U.S. net product salesReceived 152 new patient start forms for EMPAVELI® ...

Generated $459 million in 3Q 2025 revenues, including $178 million in U.S. net product salesReceived 152 new patient start forms for EMPAVELI® (pegcetacoplan) in the first two months since launch in ...

Dr S. Shahzad Mustafa looks ahead to ACAAI 2025, which will highlight advances in chronic urticaria treatment and ...

Novartis has claimed a first-in-class regulatory approval in the US for oral BTK inhibitor remibrutinib as a second-line treatment for chronic spontaneous urticaria (CSU), also known as chronic hives.

We examined costs and coverage in Utah to find the best options.

Guidance from the NHS emphasises that your symptoms could worsen if you've been under stress or if you're more physically ...